News Release

Thrombolytic Treatment For Acute Ischaemic Stroke: Consent Can Be Ethical

Peer-Reviewed Publication

BMJ

(Thrombolytic treatment for acute ischaemic stroke: consent can be ethical)

Click below to download PDF document
You will require Acrobat Reader to view file.
Click here for PDF document

Substantiating his case with a practical case study, in this week's BMJ Lindley argues that taking Doyal's approach would rule out trials of many forms of medical and surgical treatment for a wide range of disabling and life threatening conditions. He asks if it is ethical to condemn millions of "mentally incompetent" patients to no prospect of improving their health because they are unable to give fully informed consent. He argues that a better guideline for ethical trials would be "is this treatment promising" and are the potential risks deemed "acceptable by the public".

Contact:

Richard Lindley, Part-time Senior Lecturer, Department of Clinical Neurosciences, Edinburgh University, Western General Hospital, Edinburgh

t: 0131 537 5000 or mobile 0385 745487 0131 519 4136/7 (Thursday - Saturday)
f: 0131 332 7886

###


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.